A recent study utilized several metabolomic techniques such as unbiased mass spectrometry and isotope tracing to demonstrate that the loss of fructose-1,6 bisphosphatase 2 (FBP2) is a key event during sarcoma progression and a potential therapeutic target [41••]. The gene discussed is FBP2; the disease is sarcoma.